Top Calls on Wall Street: Nvidia, Apple, Tesla, UnitedHealth, Amazon, Palantir, Datadog & More

Here are the biggest calls on Wall Street on Wednesday:

Bank of America reiterates Nvidia as buy

Bank of America raised its price target on Nvidia after a meeting with management.

“Meanwhile we think valuation at 32x/25x CY26E/27E PE remains compelling given it represents <1x earnings growth rate versus broader Mag-7 and growth peers at >2x. Raise PO to $275 from $235...”

Deutsche Bank downgrades UnitedHealth to hold from buy

Deutsche downgraded the stock on valuation.

“However, with what we now see as a multi-year beat-and-raise story with no wiggle room priced into the shares, we are downgrading UNH shares to Hold.”

Bank of America reiterates Apple as buy

Bank of America raised its price target to $320 per share from $270.

“Apple’s ecosystem, its brand and its large installed base remains a competitive advantage.”

UBS reiterates Nvidia as buy

UBS raised its price target on the stock to $235 per share from $205.

“In addition to a number of new partnerships, NVDA’s new demand commentary suggests Street estimates are too low by a significant margin.”

Bank of America upgrades Wayfair to buy from neutral

Bank of America says it sees a slew of positive catalysts for the stock.

“Wayfair is well-positioned to continue to capture share as Y/Y growth accelerated to 8% vs. flattish industry growth.”

UBS upgrades Victoria’s Secret to buy from neutral

UBS says the company is “back on the growth runway.”

“Our sense is consensus is not reflecting VSCO’s operating leverage potential. We see a powerful EPS growth algorithm.”

Wedbush reiterates Palantir as outperform

Wedbush says it’s bullish ahead of earnings on November 3.

“We continue to believe Palantir has the potential to be a trillion-dollar market cap company in the next few years as the AI Revolution takes hold and AI production continues to ramp up.”

Loop reiterates Amazon as buy

Loop says it’s standing by Amazon ahead of earnings on Thursday.

“We are bullish on the stock ahead of earnings because: (1) we see several signs that AWS revenue growth has started to accelerate and the growth curve will continue to bend upward, (2) we think acceleration in retail units observed in 2Q will continue...”

Bank of America initiates Supernus Pharmaceuticals at buy

The bank called the stock an “underappreciated growth story.”

“We initiate coverage of Supernus (SUPN) with a Buy rating and $65 price objective.”

Bank of America reiterates Tesla as neutral

Bank of America raised its price target on Tesla but says the stock’s valuation is “stretched.”

“We raise our PO to $471 from $341, still based on our sum-of-the-parts.”

Canaccord initiates Viking Therapeutics at buy

Canaccord called the stock “one of the leading biotech companies in the obesity drug development space.”

“We are initiating coverage of Viking Therapeutics with a BUY rating and $106 12-month price target.”

Bank of America reiterates Datadog as buy

The firm says Datadog is a “share gainer” ahead of earnings on November 6.

“We are raising our PO to $180 (from $175) as we adjust the EV/CY26E to 15.8x from 15.4x given increasing confidence in its execution potential.”